Abstract
Fibrogenesis imperfecta is an extremely rare acquired progressive bone disorder of unknown etiology. In its course, normal bone architecture is replaced at sites by structurally unsound collagen-deficient tissue resulting in a disorganized bone structure and a skeleton that is radically susceptible to deformity and fracture. Herein, we report the case of a patient who had experienced constant bone pain and several spontaneous fractures since 1997. In 10 years’ time with the sole exception of his skull, the disease affected the entire skeleton causing a significant decrease in height and progressive disablement. Laboratory findings included elevation of serum alkaline phosphatase and C-terminal telopeptide of type 1 collagen, with normal serum calcium, phosphate, 25-hydroxy-vitamin-D, and parathyroid hormone concentrations. Monoclonal gammopathy was present with no pathological plasma cells in bone marrow. Radiological and histological results were inconclusive suggesting either osteoporosis, osteomalacia, or Paget’s disease and later on osteosclerosis. Treatment administered for the abovementioned conditions has proven to be of no effect. The findings eventually raised the possibility of fibrogenesis imperfecta ossium, which was confirmed by polarized light microscopy as well as transmission electron microscopy. The suggested therapy for the disease is melphalan that could not be initiated due to legal restrictions. Steroid monotherapy also reported to be moderately successful in one case resulted in no improvement. Paraproteinemia had been suggested not only to be a characteristic feature but also a possible etiological factor in this condition. In 2012, plasmapheresis was initiated monthly at the beginning, later on biweekly. In response, the patient’s symptoms improved dramatically supporting the abovementioned theory.
References
Baker SL, Turnbull HM (1950) Two cases of a hitherto undescribed disease characterized by a gross defect in the collagen of the bone matrix. J Pathol Bacteriol 62:132–134
Coursey C, Weber T, Dodd L, Martinez S (2007) Fibrogenesis imperfecta ossium: MR imaging of the axial and appendicular skeleton and correlation with a unique radiographic appearance. Skeletal Radiol 36:1077–1084
Ebeling PR, Smith R, Brown MA (2003) Fibrogenesis imperfecta ossium—symptomatic and histologic improvement with melphalan therapy. J Bone Miner Res 18:S415
Stamp TCB, Byers PD, All SY, Jenkins MV, Willoughby JMT (1986) Fibrogenesis imperfecta ossium remits with melphalan. Bone 2:146
Carr AJ, Smith R, Athanasou N, Woods CG (1995) Fibrogenesis imperfecta ossium. J Bone Joint Surg Br 77:820–829
Frame B, Parfitt AM (1972) Clinical aspects of metabolic bone disease. Excerpta Medica International Series, Detroit
Camus P, Perie G, Brocheriou C, Crouzet J, Prier A, Cros F (1975) Fibrogenesis imperfecta ossium. Study of 2 cases in the same family. Ann Med Intern 8–9:584–589
Golding FC (1968) Fibrogenesis imperfecta. J Bone Joint Surg Br 50-B:619–622
Christmann D, Wenger JJ, Dosch JC, Schraub M, Wackenheim A (1981) Axial osteomalacia. Comparative analysis with fibrogenesis imperfecta ossium. J Radiol 62:37–41
Epperla N, McKiernan FE, Kenney CV (2013) Radiographic findings in Waldenström's macroglobulinemia resembling fibrogenesis imperfecta ossium (FIO): a case report. Skeletal Radiol [Epub ahead of print]
Lafage MH, Schaeverbeke T, Marce S, Dehais J (1992) Inefficiency of melphalan in fibrogenesis-imperfecta-ossium associated with monoclonal gammopathy. Arthritis Rheum 35(Suppl 9):S315
Lafage MH, Schaeverbeke T, Marce S, Dehais J (1992) Fibrogenesis-imperfecta-ossium unresponsiveness to melphalan. J Bone Miner Res 7:S291
Lafage MH, Proust M, Schaeverbeke T, Dehais J (1996) Fibrogenesis imperfecta ossium: ineffectiveness of melphalan. Calcified Tissue Int 59:240–244
Wang CS, Steinbach LS, Campbell JB, Hayashi G, Yoon ST, Johnston JO (1999) Fibrogenesis imperfecta ossium: imaging correlation in three new patients. Skeletal Radiol 28:390–395
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bakos, B., Lukáts, Á., Lakatos, P. et al. Report on a case of fibrogenesis imperfecta ossium and a possible new treatment option. Osteoporos Int 25, 1643–1646 (2014). https://doi.org/10.1007/s00198-014-2675-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-014-2675-8